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ABSTRACT 
Objective: To design, synthesize and in vitro anti tubercular evaluation of some new 1,2,4–triazole derivatives. 
Methods: Novel 1,2,4–triazole derivatives were designed by using various softwares like ACD Lab Chemsketch, Molinspiration, Prediction of 
activity spectra for substances(PASS) and Schrodinger Glide XP (Grid based ligand docking with energetics). The designed molecules having 
required physico-chemical properties, drug likeness and obeying Lipinski’s rule of five were selected for the synthesis. The synthesized compounds 
were subjected to TLC, melting point determination, FTIR and 1
Results: Three derivatives (MB-2, MB-8 and MB-10) were selected for the synthesis with the help of in-silico modeling. The selected derivatives 
were synthesized by conventional method. All the synthesized compounds showed characteristic peak in FTIR and 
HNMR spectroscopic studies. Antitubercular activity of selected compounds was 
evaluated by Resazurin microtitre assay (REMA) method. 
1
Conclusion: These results are useful for further investigation in the future. 
HNMR spectroscopic studies. 
Based on the Schrodinger Glide XP score, MB-2 and MB-10 were selected for in vitro antitubercular evaluation. All the selected derivatives showed 
antitubercular activity, but the compound MB-2 showed significant antitubercular activity comparing with the compound MB-10. 
Keywords: 1,2,4-triazole derivatives, Conventional synthesis, Spectral study, In vitro antitubercular activity. 
 
INTRODUCTION 
The synthesis of high nitrogen containing heterocyclic systems has 
been attracted to many pharmaceutical and agrochemical industries. 
There is an increasing demand for the preparation of new 
antimicrobial agents due to the developing resistance towards 
conventional antibiotics. In recent years, triazole derivatives have 
acquired conspicuous significance due to their wide spectrum of 
biological activities. It plays important roles in medicine, agricultural 
and industrial fields [1]. 
A large variety of 1,2,4-triazole derivatives possess antibacterial, 
[2,3,4,5] antifungal [2,3,4,5,6,7,8], antitumor [9], antiviral [10], 
antiinflammatory, anticonvulsant, antitubercular (5), analgesic, 
enzyme inhibitor, herbicides and plant growth regulators [7]. 
In-silico molecular modification was the most important preliminary 
step in the rational drug designing of novel drugs. In our previous 
study, various 1,2,4-triazole derivatives were designed by 
preliminary in silico methods using various softwares and three 
derivatives were synthesized and their anticancer properties were 
evaluated [11]. Now our ongoing investigations have been directed 
toward the design and synthesis of some new 1,2,4-triazole 
derivatives and the investigation of in vitro antitubercular activity of 
newly synthesized compounds, an attempt to provide a direction for 
further research.  
MATERIALS AND METHODS 
In-silico molecular modification 
Different proposed derivatives were screened for different physico-
chemical properties by using various softwares. ACD Lab 
Chemsketch was used for 3-D drawing, optimizing and calculating 
various physicochemical descriptors of the proposed molecules. The 
Molinspiration software was used for calculating logP values, 
Lipinski’s rule of five and drug likeness. The proposed molecules 
were screened for whether they obey the rule of five or not. The 
general biological activities of proposed molecules were predicted 
by using PASS (Prediction of activity spectra for substances) 
software. Schrodinger Glide XP (Grid based ligand docking with 
energetics) software was used for the molecular docking of 
proposed molecules. Three 1,2,4-triazole derivatives were selected 
for synthesis with the help of these selection parameters. They are 
2- [(Diethyl amino) methyl] -5- (4-hydroxy phenyl) -4- {[(4-nitro 
phenyl) methylidene] amino}-1,2,4-triazolin-3-thione. (MB-2) 
2- (Morpholin-4-yl methyl) -5- (4-hydroxy phenyl) -4- {[(4-nitro 
phenyl) methylidene] amino}-1,2,4-triazolin-3-thione. (MB-8) 
2- [(Diethyl amino) methyl] -5- (4-hydroxy phenyl) -4- {[furan-2-yl 
methylidene] amino}-1,2,4-triazolin-3-thione. (MB-10) 
Synthesis of selected 1,2,4-triazole derivatives 
The selected compounds were synthesized by conventional method 
through a series of four steps. 
Step 1: Synthesis of aromatic hydrazide from an aromatic ester 
and hydrazine hydrate. 
Methyl 4- hydroxy benzoate 1.52g (0.01 mole) and 80٪ hydrazine 
hydrate 0.97 ml (0.02 mole) were refluxed in absolute ethanol (50 
ml) for 18 h. The reaction mixture was concentrated and the ethanol 
was removed by distillation, condensation and then the reaction 
mixture was cooled in an ice bath with continuous stirring and kept 
in the room temperature for 3-4 h. The solid product thus separated 
out was filtered, dried and recrystallized from ethanol. Yield and 
melting point of product obtained were determined. A single spot on 
the TLC plate established the purity of the compound. The solvent 
system used was n-hexane: ethyl acetate (8:2). 
Step 2: Synthesis of 4-amino 5-aryl 1,2,4-triazolin-3-thione 
through the formation of potassium dithiocarbazinate from 
aromatic hydrazide. 
13.7g (0.1 mole) 4-hydroxybenzohydrazide was dissolved in 200 ml 
of absolute alcohol containing 5.6g (0.1 mole) of potassium 
hydroxide at room temperature. 12.5 ml of carbon disulphide was 
added in parts and stirred for 16 h at room temperature. Then 100 
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ml of diethyl ether was added and stirred for further 3 h. The 
resultant product was separated and dried. Yield, R f  value and 
melting point of the product were recorded. 
10.3g hydrazine hydrates (0.1 mole, 99%) was gradually added to 
Potassium dithiocarbazinate dissolved in 100 ml of water with 
stirring and refluxed for 8 h during which hydrogen sulphide gas 
evolved and the colour of the reaction mixture was changed to deep 
green. It was then cooled to 0-50C and acidified with hydrochloric 
acid to pH 1. The resultant product was isolated by filtration and 
recrystalized from ethanol. Yield, melting point and R f  value of the 
product were recorded. 
Step 3: Synthesis of different Schiff’s bases by reacting 4-amino -
5- aryl 1,2,4-triazolin-3-thione with different aromatic 
aldehydes. 
2-3 drops of concentrated sulphuric acid were added to the solution 
of 0.01 mole 4-amino-5-(4-hydroxyphenyl)–1,2,4-triazolin-3-thione 
in 20 ml of ethanol. 0.01 mole of different benzaldehyde derivative 
was added and refluxed for 2-6 h. Then the reaction mixture was 
cooled to 00C and the precipitate obtained was filtered, dried and 
recrystallized from ethanol. 
Step 4: Synthesis of different Mannich bases (final compounds) 
by treating above Schiff’s bases with various secondary amines 
in the presence of formaldehyde.  
Various secondary amines (0.01 mole) were gradually added to the 
solution of Schiff’s base (0.01 mole) in 12 ml of dry ethanol. 38% 
formaldehyde solution (0.8 ml, 0.015 mole) was added to it. The pH 
of the solution was maintained between 3 and 4 by using 
concentrated hydrochloric acid. Then the reaction mixture was 
stirred for 1 h at room temperature and allowed to stand overnight 
at 00C. The precipitate obtained was filtered, dried and recrystallized 
from ethanol. Yield, melting point and R f  value of the product were 
recorded.  
For the synthesis of compound MB-2, Para nitrobenzaldehyde and 
diethyl amine were used in Step-3 and Step-4 respectively. For MB-
8, Para nitrobenzaldehyde and morpholine were used in Step-3 and 
Step-4 respectively. For the compound, MB-10 furfuraldehyde and 
diethyl amine were used in Step-3 and Step-4 respectively. 
Characterization of synthesized compound by spectral study 
IR Spectrum 
IR spectra were recorded by using KBr pellets in the range of 4000 – 
500 cm-1 on Jasco FTIR Model 4100 Type A to elucidate the 
structure of the compounds. 
1
Proton NMR (300 MHZ) spectra were recorded in CDCl
HNMR Spectrum 
3
In vitro antitubercular activity 
. Chemical 
shifts were recorded in parts per million downfield with reference to 
internal standard Tetra Methyl Silane (TMS) on Bruker ultra shield 
model 400. 
Antitubercular activity of selected compounds was evaluated by 
Resazurin microtitre assay (REMA) method. Mycobacterium 
tuberculosis H37Rv used for the evaluation was procured from MTCC, 
Chandighar, India. Black view, flat bottom 96-well microplates were 
used for the experiment. The initial drug dilutions was prepared by 
using dimethyl sulphoxide and subsequent two fold dilutions were 
prepared in the microplates by using 0.1 ml of 7H9GC broth. 100 µl 
of 2000CFU/ml of test organism in 7H9GC broth was added to each 
well of 96 well micro titre plate containing test compounds. Three 
controls- medium only, drug and medium, test organism and 
medium were prepared and all are incubated at 37°C for seven days. 
On 7th
RESULTS 
 day alamar blue dye solution (20 μl alamar blue solution and 
12.5 ml of 20% Tween 80) was added to all the wells and the plates 
were re-incubated at 37 °C for 24 h. Results were recorded at 365 
nm using a microplate reader. 
In the present study, in-silico molecular modifications of proposed 
derivatives were done by using different softwares. 3D- drawing, 
optimizing and calculating various descriptors of proposed 
derivatives were done by using ACD Lab Chemsketch software. The 
results are shown in table 1. 
The molinspiration software was used to study the LogP values, 
violation of Lipinski’s rule of five and drug likeness by comparing 
with already existing standard drugs. The results are shown in 
tables 2, 3, 4 and fig. 1. 
 
 
Fig. 1: Drug-likeness model score of compound MB2 
  
Table 1: Molecular descriptors of proposed 1,2,4-triazole derivatives 
Comp. Molar Refractivity (Cm3 Molar Volume (Cm) 3 Parachor ) 
(Cm3





Mi log P 
[24] 
 
MB-1 122.05±0.5 333.4±7.0 881.1±8.0 48.7±7.0 48.38±0.5 4.638 
MB-2 118.51±0.5 320.1±7.0 868.9±8.0 54.2±7.0 46.98±0.5 3.313 
MB-3 125.66±0.5 356.0±7.0 919.8±8.0 44.5±7.0 49.81±0.5 3.457 
MB-4 124.48±0.5 322.7±7.0 880.0±8.0 55.2±7.0 49.35±0.5 4.794 
MB-5 120.94±0.5 309.4±7.0 867.7±8.0 61.8±7.0 47.94±0.5 3.469 
MB-6 128.09±0.5 345.3±7.0 918.6±8.0 50.0±7.0 50.77±0.5 3.613 
MB-7 121.26±0.5 313.3±7.0 860.5±8.0 57.0±7.0 48.07±0.5 3.732 
MB-8 117.72±0.5 299.8±7.0 848.3±8.0 64.0±7.0 46.67±0.5 2.407 
MB-9 124.87±0.5 335.7±7.0 899.2±8.0 51.4±7.0 49.5±0.5 2.551 
MB-10 105.02±0.5 289.2±7.0 765.4±8.0 49.0±7.0 41.63±0.5 2.612 
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Table 2: SMILES and cLogP values of proposed 1,2,4-triazole derivatives 
  Code Substitution Smile Notation MiLogP 
 










 MB-3 R1 = H,R2 = 





 MB-4 R1 = R2= Cl R3 Clc4ccc(/C=N/N2C(=S)N(CN1CCCCC1)N=C2c3ccc(O)cc3)c(Cl)c4  = 
 
4.794 











  MB-7 R1 = R2= Cl R3 Clc4ccc(/C=N/N2C(=S)N (N=C2c1ccc(O)cc1)CN3CCOCC3)c(Cl)c4  = 
 
3.732 









R1 = H,R2=N(CH3)2 









Table 3: Lipinski’s rule analysis of standard drugs and proposed 1,2,4-triazole derivatives 
Comp MiLog P M. W n. HDO n. HAC n. rotb n. violation 
INHEthambutolStreptomycin -0.9690.35-
5.35 
137.14204.31581.58 3416 441 9 199 003 
 MB-1 4.638 450.395 1 6 7 0 
MB-2 3.313 426.502 1 9 8 0 
MB-3 3.457 424.574 1 7 8 0 
MB-4 4.794 462.406 1 6 5 0 
MB-5 3.469 438.513 1 9 6 0 
MB-6 3.613 436.585 1 7 6 0 
MB-7 3.732 464.378 1 7 5 0 
MB-8 2.407 440.485 1 10 6 0 
MB-9 2.551 438.557 1 8 6 0 
MB-10 2.612 371.466 1 7 7 0 
 Comp – Compound; M. W- molecular weight; nHDO- number of hydrogen bond donar; nHDA- number of hydrogen bond acceptor; n. rotb- number 
of rotatable bonds. 
 









Nuclear receptor ligand 
INH - 1.39 -1.45 -1.65 -2.33 
Ethambutol -0.30 -0.16 -0.44 -0.68 
Streptomycin 0.09 -0.16 -0.17 -0.18 
MB-1 -0.95 -1.08 - 0.99 - 1.20 
MB-2 -1.02 -1.06 -1.05 -1.17 
MB-3 - 0.88 -1.03 -0.89 -1.08 
MB-4 -0.87 -0.99 -0.94 -1.13 
MB-5 -0.94 -0.98 -0.99 -1.11 
MB-6 -0.81 -0.95 -0.85 -1.02 
MB-7 -0.94 -1.07 -0.91 -1.16 
MB-8 -1.01 -1.06 -0.97 -1.14 
MB-9 -0.88 -1.03 -0.82 -1.05 
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 Comp – Compound 
The PASS software was used to predict the general biological 
activities of proposed molecules. The result of prediction is 
presented as the list of activities with appropriate Pa (Probability to 
be active) and Pi (Probability to be inactive) sorted in descending 
order of the difference (Pa-Pi)>0. Pa and Pi are the estimates of 
probability for the compound to be active or inactive respectively 
for each type of activity from the biological activity spectrum. Their 
values vary from 0.000 to 1.000. 
If Pa > 0.7, the compound is very likely to reveal this activity in 
experiments, but in this case the chance of being the analogue of the 
known pharmaceutical agents for this compound is also high. 
If 0.5 < Pa < 0.7, the compound is likely to reveal its activity in 
experiments, but this probability is less, and the compound is not so 
similar to the known pharmaceutical agents. 
If Pa < 0.5, the compound is unlikely to reveal its activity in 
experiments, but if the presence of this activity is confirmed in the 
compound, it might be a new chemical entity. The results are shown 
in table 5. 
The synthesized compounds were characterized by FTIR and 1HNMR 
spectroscopic methods. The FTIR report for the Schiff’s base 
obtained in the synthesis of compound MB-2 is shown in graph 1. 
FTIR report for compound MB-2 is shown in graph 2 and 1
 
HNMR 
report for compound MB-2 is shown in graph 3. 
 
Graph 1: FTIR report for the Schiff’s base obtained in the 
synthesis of compound MB-2 
 
Table 5: PASS of proposed 1,2,4-triazole derivatives for anti-
tubercular activity 
Compound Pa Pi Pa-Pi 
MB-1 0.384 0.037 0.347 
MB-2 0.635 0.005 0.630 
MB-3 0.484 0.013 0.471 
MB-4 0.445 0.025 0.420 
MB-5 0.523 0.016 0.507 
MB-6 0.444 0.025 0.419 
MB-7 0.359 0.051 0.308 
MB-8 0.534 0.015 0.519 
MB-9 0.455 0.023 0.432 
MB-10 0.589 0.006 0.583 
 
With the help of these selection parameters three analogues were 
selected for the synthesis. They were named as MB-2, MB-8 and MB-
10. The selected compounds were synthesized by conventional 
method through a series of four steps. Purity of the synthesized 
compounds was ascertained by TLC and melting point 
determination by open capillary tube method. The results are shown 
in table 6.  
Schrodinger Glide XP software was used for predicting the protein-
ligand binding modes. In this study, the compound having high (-) 
value is considered as the best one. The docking scores are 
presented in table 7 and the docking images are shown in fig. 2. 
Based on the Schrodinger Glide XP score, MB-2 and MB-10 were 
selected for in vitro antitubercular evaluation. The selected 
derivatives showed antitubercular activity, but the compound MB-2 
showed significant antitubercular activity comparing with the 
compound MB-10. The results are shown in table 8. 
 












MB-2 426.502 260-262 0.4 
MB-8 440.485 263-265 0.82 
 MB-10 371.466 225-227 0.58 




Graph 2: FTIR report for compound MB-2 (Mannich base) 
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Table 7: Schrodinger Glide XP scores of selected 1,2,4-triazole 
derivatives Protein used for docking: Glutamine synthetase; 
PDB ID: 1HTO 
HNMR report for compound MB-2 
 Compound  Glide score 
MB- 2 -5.91 
MB- 8 -4.60 
 MB- 10 -5.89 
 
 
Fig. 2: Docking image of (a) MB-2 and (b) MB-10 to Glutamine 
synthetase (1HTO) 
 
Table 8: In vitro antitubercular activity of selected 1,2,4-triazole 
derivatives 
Conc. (µg/ml) Percentage inhibition 
MB-2 MB-10 
0 0 0 
50 45 39 
100 52 48 
150 64 59 
200 77 70 
250 80 73 
Conc. – Concentration 
DISCUSSION 
The in-silico molecular modifications of proposed derivatives were 
done by using ACD Lab Chemsketch, Molinspiration, PASS and 
Schrodinger GlideXP. With the help of these parameters, three 
derivatives (MB-2, MB-8 and MB-10) were selected for the synthesis. 
Compounds synthesized by the conventional method were 
characterized by TLC, melting point determination, FTIR and 1
CONCLUSION 
HNMR 
spectroscopic studies. All these evaluations ensured the synthesized 
compounds. In the in vitro antitubercular screening, all the selected 
derivatives showed antitubercular activity but the compound MB-2 
showed significant activity comparing with other agent. Of course 
this compound needs further studies and it may give valuable 
results. So it is clear that further works needed to be done in the 
future for the development of clinically useful chemotherapeutic 
agent.  
In summary, the prime objective of the present work was to design, 
synthesize and biologically screen some of the 1, 2, 4-triazole 
derivatives. Based on that particular objective, various 1, 2, 4-
triazole derivatives were designed by preliminary in silico methods 
using various softwares. Based on the in silico results, three 
derivatives were synthesized by the conventional method and the 
purity of the compounds thus synthesized was ascertained by 
consistency in melting point and R f value and characterized by IR 
and 1
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